Lenalidomide (Revlimid®) - a novel immunomodulatory drug (IMiD®) from bench to bedside. Part 1, Myelodysplastic syndromes (H. Lee Moffitt Cancer Center & Research Institute, 2006)
Cancer control, ISSN 1073-2748 vol. 13, suppl., December 2006
Keywords: IMiD; Myelodysplastic Syndromes; imunologické faktory; myelodysplastické syndromy; thalidomid; Immunologic Factors; Thalidomide; Lenalidomide; hematologie a transfuzní lékařství; farmakoterapie; onkologie; Revlimid